Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Reperfusion Injury D015427 65 associated lipids
Pain D010146 64 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Weight Loss D015431 56 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Parkinson Disease D010300 53 associated lipids
Nerve Degeneration D009410 53 associated lipids
Asthma D001249 52 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Osteosarcoma D012516 50 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Espey LL et al. Decrease in ovarian platelet-activating factor during ovulation in the gonadotropin-primed immature rat. 1989 Biol. Reprod. pmid:2804200
Orlov SM et al. [Mechanism of suppression of human peripheral blood lymphocyte proliferation by platelet activation factor]. 1989 Biull Eksp Biol Med pmid:2804305
O'Neill C et al. Supplementation of in-vitro fertilisation culture medium with platelet activating factor. 1989 Lancet pmid:2476641
VornovitskiÄ­ EG et al. [Interactions of PAF and its antagonists in the guinea pig atrial myocardium]. 1989 Biull Eksp Biol Med pmid:2804312
Bekemeier H and Sänze JU Vasodepression ex vivo after administration of inflammatory mediators in vivo in the rat. 1989 Agents Actions pmid:2476918
Tkachuk VA et al. Receptor-operated channels in human platelets. 1989 J. Protein Chem. pmid:2477022
Muirhead EE et al. Biologic contrasts between medullipin I and vasoactive glyceryl compounds. 1989 Am. J. Med. Sci. pmid:2764021
Silva PM et al. Late eosinophil mobilization induced by PAF-acether in the pleural cavity of rats. 1989 Braz. J. Med. Biol. Res. pmid:2638199
Yeo YK et al. The effect of long-term consumption of fish oil on platelet-activating factor synthesis in rat renal microsomes. 1989 Biochem. Biophys. Res. Commun. pmid:2543394
Nakashima S et al. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils. 1989 J. Immunol. pmid:2545786
Denizot Y and Benveniste J [Contamination of fermented milk products by proinflammatory autacoid paf-acether]. 1989 C. R. Acad. Sci. III, Sci. Vie pmid:2510911
Aglietta M et al. [GM-CSF: target cells and their response kinetics]. 1989 Haematologica pmid:2512230
Sturk A et al. Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids. 1989 Biochim. Biophys. Acta pmid:2512985
Gomez-Cambronero J et al. Calcium is necessary but not sufficient for the platelet-activating factor release in human neutrophils stimulated by physiological stimuli. Role of G-proteins. 1989 J. Biol. Chem. pmid:2513317
Reinhold SL et al. Phospholipid remodeling in human neutrophils. Parallel activation of a deacylation/reacylation cycle and platelet-activating factor synthesis. 1989 J. Biol. Chem. pmid:2513324
Squinto SP et al. Platelet-activating factor stimulates a fos/jun/AP-1 transcriptional signaling system in human neuroblastoma cells. 1989 J. Neurosci. Res. pmid:2513416
DiCorleto PE and de la Motte CA Thrombin causes increased monocytic-cell adhesion to endothelial cells through a protein kinase C-dependent pathway. 1989 Biochem. J. pmid:2513808
Chao W et al. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells. 1989 Biochem. J. pmid:2775221
Touvay C et al. Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen- induced bronchoconstriction in the guinea-pig. 1989 Biochem. Biophys. Res. Commun. pmid:2775253
Leyravaud S and Benveniste J Regulation of cellular retention of paf-acether by extracellular pH and cell concentration. 1989 Biochim. Biophys. Acta pmid:2775773
Shukla SD et al. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets. 1989 Mol. Pharmacol. pmid:2539556
Franzone JS et al. Doxofylline exerts a prophylactic effect against bronchoconstriction and pleurisy induced by PAF. 1989 Eur. J. Pharmacol. pmid:2776832
Montrucchio G et al. Release of platelet-activating factor from ischemic-reperfused rabbit heart. 1989 Am. J. Physiol. pmid:2539755
Gasser H et al. Effect of platelet-activating factor (PAF) administration in chronically instrumented sheep--analysis of PAF in plasma. 1989 Prog. Clin. Biol. Res. pmid:2780708
Pretolani M et al. PAF-acether and experimental anaphylaxis as a model for asthma. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2540093
Bonavida B et al. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock. 1989 Prog. Clin. Biol. Res. pmid:2780710
Heuer H Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity. 1989 Prog. Clin. Biol. Res. pmid:2780739
Mandi Y et al. Effect of the platelet-activating factor antagonist BN 52021 on human natural killer cell cytotoxicity. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2540096
Weber KH and Heuer H Structure-activity relationships and effects of platelet-activating factor antagonists in the hetrazepine series. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2540098
Lopez Diez F et al. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia. 1989 J. Clin. Invest. pmid:2540221
Wirthmueller U et al. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine. 1989 J. Immunol. pmid:2540238
O'Flaherty JT et al. Bidirectional effects of protein kinase C activators. Studies with human neutrophils and platelet-activating factor. 1989 J. Biol. Chem. pmid:2540163
Stewart AG and Phillips WA Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages. 1989 Br. J. Pharmacol. pmid:2553184
Woodward DF et al. Platelet-activating factor causes goblet cell depletion in the conjunctiva. 1989 Eur. J. Pharmacol. pmid:2555201
Filipponi F et al. Prolongation of guinea pig-to-rat xenograft survival with BN 52063, a specific antagonist of platelet-activating factor. 1989 Ital J Surg Sci pmid:2483404
Sanchez Crespo M and Nieto ML Modulation of PAF biosynthesis in human polymorphonuclear leukocytes. The role of phorbol esters and protein kinases. 1989 Agents Actions pmid:2711927
Zijlstra FJ et al. The effects of PAF-acether and FMLP on eicosanoid production in guinea pig alveolar macrophages. 1989 Agents Actions pmid:2711928
Nijkamp FP et al. Role of platelet activating factor in the endotoxin induced tracheal hyperreactivity to histamine in the guinea pig. 1989 Agents Actions pmid:2711929
Benveniste J PAF-acether (platelet-activating factor). 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526498
Oliver JL et al. Effect of PAF acether on oriented egg phosphatidylcholine multibilayers; interaction with cholesterol; comparison to lyso-PC and lyso-PAF. 1989 Agents Actions pmid:2711930
Hsueh W and Sun XM Tumor necrosis factor-induced bowel necrosis: the role of platelet-activating factor. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526499
Capron M Eosinophils: receptors and mediators in hypersensitivity. 1989 Clin. Exp. Allergy pmid:2713741
Cirino G and Wallace JL A superfusion bioassay for platelet-activating factor. 1989 Can. J. Physiol. Pharmacol. pmid:2713756
Levy C et al. High affinity acceptor sites in guinea pig brain for [3H]52770 RP, a PAF antagonist. 1989 Fundam Clin Pharmacol pmid:2714731
Suematsu M et al. In vivo visualization of oxyradical-dependent photoemission during endothelium-granulocyte interaction in microvascular beds treated with platelet-activating factor. 1989 J. Biochem. pmid:2808326
Hansel W et al. Low molecular weight lipid-soluble luteotrophic factor(s) produced by conceptuses in cows. 1989 J. Reprod. Fertil. Suppl. pmid:2810227
Thatcher WW et al. Antiluteolytic effects of bovine trophoblast protein-1. 1989 J. Reprod. Fertil. Suppl. pmid:2810237
Smal MA et al. Production of antibodies to platelet activating factor. 1989 Mol. Immunol. pmid:2811869
Hemmendinger S et al. Mitogenic activity on human arterial smooth muscle cells is increased in the plasma of patients undergoing hemodialysis with cuprophane membranes. 1989 Nephron pmid:2812169
Braquet P and Hosford D The potential role of platelet-activating factor (PAF) in shock, sepsis and adult respiratory distress syndrome (ARDS). 1989 Prog. Clin. Biol. Res. pmid:2675060
Hermán F et al. Decreased sensitivity of platelets to platelet-activating factor in migraine patients during the headache-free interval. 1989 Thromb. Haemost. pmid:2814933
Mencia-Hurerta JM et al. The role of platelet-activating factor (PAF) in immune and cytotoxic processes. 1989 Prog. Clin. Biol. Res. pmid:2675061
Heuer H and Casals-Stenzel J The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086. 1989 Prog. Clin. Biol. Res. pmid:2675077
Godard P et al. [Physiopathology of asthma]. 1989 Ann. Biol. Clin. (Paris) pmid:2675684
Lefer AM Platelet activating factor (PAF) and its role in cardiac injury. 1989 Prog. Clin. Biol. Res. pmid:2678133
Page CP and Coyle AJ The interaction between PAF, platelets and eosinophils in bronchial asthma. 1989 Eur Respir J Suppl pmid:2679601
McCusker MT et al. Effect of topical capsaicin on the cutaneous responses to inflammatory mediators and to antigen in man. 1989 J. Allergy Clin. Immunol. pmid:2471719
Esplugues JV et al. Local opioid-sensitive afferent sensory neurones in the modulation of gastric damage induced by Paf. 1989 Br. J. Pharmacol. pmid:2758231
Stanton AW et al. Platelet-activating factor (Paf) antagonist, WEB 2086, protects against Paf-induced hypotension in Macaca fascicularis. 1989 Br. J. Pharmacol. pmid:2758235
Dixon EJ et al. The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin. 1989 Br. J. Pharmacol. pmid:2758238
Hébert RL et al. Inhibition of platelet-activating factor induced renal hemodynamic and tubular dysfunctions with L-655,240, a new thromboxane-prostaglandin endoperoxide antagonist. 1989 Can. J. Physiol. Pharmacol. pmid:2758373
Yaghi A et al. Influence of platelet-activating factor on leukotriene D4-induced contractions of the guinea pig parenchymal strip. 1989 Can. J. Physiol. Pharmacol. pmid:2758374
Konturek SJ et al. Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats. 1989 Eur. J. Pharmacol. pmid:2759176
Peterson JR et al. Platelet activating factor antagonist design. 3. X-ray crystal structure and intermolecular crystal lattice interactions of methyl trans-4-acetoxymethyl-4,5-dihydro-2,5-bis(3,4-methylenedioxyphenyl)- 3-furancarboxylate. 1989 Acta Crystallogr C pmid:2604943
Lister MD et al. Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosadienoic acid, and p-bromophenacyl bromide. 1989 J. Biol. Chem. pmid:2498315
Miyazaki H et al. Lactone and cyclic ether analogues of platelet-activating factor. Synthesis and biological activities. 1989 Chem. Pharm. Bull. pmid:2605681
Miyazaki H et al. Synthesis and antagonistic activities of enantiomers of cyclic platelet-activating factor analogues. 1989 Chem. Pharm. Bull. pmid:2605682
Fortes ZB et al. Functional changes in the microcirculation of alloxan-induced diabetic rats. 1989 Gen. Pharmacol. pmid:2606330
Pletscher A et al. LDL induced shape change reaction of platelets is not due to PAF. 1989 Thromb. Res. pmid:2609294
Han GQ et al. [The isolation and identification of PAF inhibitors from Piper wallichii (Miq.) Hand-Mazz and P. hancei Maxim]. 1989 Yao Xue Xue Bao pmid:2609983
Damas J et al. Endotoxin shock, kinin system and PAF-acether in the rat. 1989 Adv. Exp. Med. Biol. pmid:2610092
Bossant MJ et al. Quantitation of paf-acether by release of endogenous platelet serotonin assessed by liquid chromatography with electrochemical detection. 1989 Anal. Biochem. pmid:2610359
Buckley TL and Hoult JR Platelet activating factor is a potent colonic secretagogue with actions independent of specific PAF receptors. 1989 Eur. J. Pharmacol. pmid:2542064
Fitzgerald MF et al. Release of PAF-acether and eicosanoids from guinea-pig alveolar macrophages by FMLP: effect of cyclo-oxygenase and lipoxygenase inhibition. 1989 Eur. J. Pharmacol. pmid:2548873
Zavoico GB et al. IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis. 1989 J. Immunol. pmid:2497185
Munoz NM et al. Evidence for platelet-activating factor secretion during immune activation in dogs. 1989 J. Appl. Physiol. pmid:2732178
Yanagihara Y et al. Immunopharmacological studies on TBX, a new antiallergic drug (3). Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs. 1989 Jpn. J. Pharmacol. pmid:2478743
Leyravaud S et al. Biosynthesis of paf-acether. X. Phorbol myristate acetate-induced paf-acether biosynthesis and acetyltransferase activation in human neutrophils. 1989 J. Immunol. pmid:2732470
Martiny-Baron G and Scherer GF Phospholipid-stimulated protein kinase in plants. 1989 J. Biol. Chem. pmid:2530218
Joseph R et al. Platelet-activating factor and red blood cells. 1989 Thromb. Res. pmid:2734734
Jackson SP and Salem HH Platelet aggregating activity in the plasma of patients with established thrombosis. 1989 Aust N Z J Med pmid:2504137
Dubovsky SL et al. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. 1989 Arch. Gen. Psychiatry pmid:2735813
Rodrigues FA et al. Hypothesis: a central role for platelet activating factor in the pathogenesis of pre-eclampsia. 1989 Med. Hypotheses pmid:2739597
Pirotzky E et al. [Renal diseases and platelet activating factor]. 1989 Pediatrie pmid:2740184
Ng DS and Wong K Effect of platelet-activating factor (PAF) on cytosolic free calcium in human peripheral blood mononuclear leukocytes. 1989 Res. Commun. Chem. Pathol. Pharmacol. pmid:2740622
Baker RC et al. Effects of ethanol on human platelets stimulated with platelet-activating factor, a biologically active ether phospholipid. 1989 Alcohol. Clin. Exp. Res. pmid:2557776
Stewart AG CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages. 1989 Clin. Exp. Pharmacol. Physiol. pmid:2558827
Kudolo GB and Harper MJ Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits. 1989 Biol. Reprod. pmid:2559778
Beyer CF et al. Cryogenic induced ocular HSV-1 reactivation is enhanced by an inhibitor of the lipoxygenase pathway. 1989 Curr. Eye Res. pmid:2560693
VornovitskiÄ­ EG et al. [The blocking action of platelet-activating factor (PAF) on the calcium currents of the atrial fibers in the frog and guinea pig]. 1989 Biull Eksp Biol Med pmid:2561348
Hoshikawa-Fujimura AY et al. PAF-acether, superoxide anion and beta-glucuronidase as parameters of polymorphonuclear cell activation associated with cardiac surgery and cardiopulmonary bypass. 1989 Braz. J. Med. Biol. Res. pmid:2561459
Whatley RE et al. The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C. 1989 J. Biol. Chem. pmid:2703492
Handley DA et al. Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activity. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2546390
Dray F et al. Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the rat. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2546391
Alonso MT et al. Monitoring of the activation of receptor-operated calcium channels in human platelets. 1989 Biochem. Biophys. Res. Commun. pmid:2546547
Remy E et al. Inhibition of platelet-activating factor biosynthesis via the acetyltransferase by arachidonic and oleic acids in ionophore A23187-stimulated bovine neutrophils. 1989 Biochim. Biophys. Acta pmid:2505852
Kroegel C et al. Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils. 1989 Biochem. Biophys. Res. Commun. pmid:2546554
O'Flaherty JT et al. Receptor-independent metabolism of platelet-activating factor by myelogenous cells. 1989 FEBS Lett. pmid:2546802
Yoshikawa T et al. [Role of polymorphonuclear leukocytes and oxygen-derived free radicals in the formation of gastric mucosal lesions induced by platelet-activating factor]. 1989 Nihon Shokakibyo Gakkai Zasshi pmid:2547098
Beume R and Kilian U [The significance of platelet activating factor and its antagonists in bronchial asthma]. 1989 Med. Klin. (Munich) pmid:2547143